COVID-19: The therapeutic landscape

Therapeutics for hospitalized COVID-19 patients were identified through a robust research response with several lessons learned: clinical trial data should guide therapeutic use, results should not be extrapolated between disease stages, and robust studies should be designed to give clinically relev...

Descripción completa

Detalles Bibliográficos
Autores principales: Paules, Catharine I., Fauci, Anthony S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057546/
https://www.ncbi.nlm.nih.gov/pubmed/33899041
http://dx.doi.org/10.1016/j.medj.2021.04.015
Descripción
Sumario:Therapeutics for hospitalized COVID-19 patients were identified through a robust research response with several lessons learned: clinical trial data should guide therapeutic use, results should not be extrapolated between disease stages, and robust studies should be designed to give clinically relevant data. These lessons should be applied to the outpatient research response.

Ejemplares similares